Daily Roundup

Pro Medicus has locked in a significant long-term win, securing a A$43 million, seven-year contract with Virtua Health, an academic health system in South Jersey. The deal centers on rolling out Visage 7, the company's unified enterprise imaging platform, across Virtua's facilities. What's particularly noteworthy is that the entire system will run in the cloud, with implementation kicking off immediately and a go-live targeted for late Q2 or early Q3 2027.

**

Data centre operator NEXTDC has had to pump the brakes on its financial expectations for the year ahead. Delays in electricity network upgrades by Jemena are pushing back a planned power increase at its M3 Melbourne facility into FY28, which ripples through to revenue and profitability. The company has revised its FY27 net revenue guidance down to A$475 million to A$500 million from A$615 million to A$640 million, while Underlying EBITDA guidance has dropped to A$245 million to A$265 million from A$385 million to A$410 million. Capital expenditure guidance was also trimmed to A$4.5 billion to A$5 billion. On the bright side, NEXTDC maintains solid liquidity of A$8.675 billion and remains compliant with its financial covenants, so the company isn't in any immediate distress—just dealing with timing headwinds beyond its control.

**

Gold miner Northern Star Resources delivered its September quarter update, reporting 364,000 ounces of gold sold at an all-in sustaining cost of A$3,217 per ounce. The standout achievement was completing the tie-in of its KCGM mill, which is now in early commissioning stages. The quarter generated a net mine cash flow of A$210 million, and the company is sitting on A$1.2 billion in cash and bullion. Northern Star's full-year guidance remains unchanged at 1,500 to 1,650 thousand ounces of gold sold, though production is expected to skew toward the second half as the expanded KCGM processing facility continues ramping up.

**

BSA Ltd is making a strategic push into aerial technology, announcing plans to acquire Eonetics, an Australian developer of tethered-drone and remote infrastructure solutions. The binding agreement is subject to the usual regulatory approvals and shareholder sign-off, with completion expected shortly after BSA's 2026 annual general meeting. The deal pairs BSA's established infrastructure services with Eonetics' proprietary aerial capabilities, positioning the combined entity to offer more comprehensive infrastructure solutions.

**

In the biotech space, Microba Life Sciences and Genetic Signatures have tweaked the terms of their proposed merger. Under the revised arrangement, Microba shareholders will own 60% of the merged entity, down from the previously agreed 67%, while existing Genetic Signatures shareholders will hold 40%, up from 33%. Everything else remains on the table, and the updated terms are heading to ASX for review before being detailed in an addendum to the Notice of AGM.